IPO

Global Longlife Hospital and Research Limited IPO

BSE SME

Listed On: May 4, 2022 at ₹ 141.1

₹ 280000 /2000 Shares
*Min Investment

Check Allotment

21 Apr, 2022

Open Date

25 Apr, 2022

Close Date

30 Apr, 2022

Allotment Date

04 May, 2022

Listing Date
IPO Issue Details
  • Issue Price ₹140 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 3,500,000 Eq Shares of ₹10(aggregating up to ₹49.00 Cr)
  • Listing at BSE SME
  • List Price 141.1
  • Listing Date 2022-05-04
  • Lead Manager Interactive Financial Services Ltd
  • Registrar Bigshare Services Pvt Ltd
IPO Details
  • Retail Portion N/A
IPO Documents
IPO Details


Global Longlife Hospital and Research Limited IPO is an SME IPO, priced at ₹140 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform.

The IPO bidding window is open from Apr 21, 2022 to Apr 25, 2022. The allotment is expected to be finalized on Apr 30, 2022, and the tentative listing date is May 4, 2022.


The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
IPO Subscription Analysis And Details
Retail
1.40x
Total
1.50x
As onQIB / NIIRetailTotal
Shares Offered / Reserved1,662,0001,662,0003,324,000
Day 1 21-04-22 05:00 PM
0.13 x0.16 x0.14 x
Day 2 22-04-22 05:00 PM
0.62 x0.71 x0.67 x
Day 3 25-04-22 05:00 PM
1.60 x1.40 x1.50 x
Valuations
Earnings Per Share (EPS) ₹0.99/-
P/E Ratio 141.97
RoNW 11.54%
Net Asset Value (NAV) - Post Issue ₹55.21/-
Company Financials
In Crs.
In Cr.
31-Mar-2131-Mar-2031-Mar-19
Assets35.9041.9143.29
Revenue32.7633.6534.69
Profit After Tax1.03(0.86)1.36
About Company

Global Longlife Hospital and Research Limited provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers ("NABH Accredited").
The company is known as a Multi-Speciality Tertiary Care Hospital of Gujarat with 110 beds well equipped for Medical & Surgical Specialities. As of December 31, 2021, the company has 11 full-time consultants, and a team of more than 30 experienced doctors as consultants to serve patients. The company's staff strength also comprises 37 nurses and more than 50 paramedical, pharmacists, corporate and support staff. Global Longlife Hospital is located in Ahmedabad.

Read More
- Promoter(s)

Mr. Sureshkumar Babulal Jani

Mr. Dhruv Sureshkumar Jani

Pre Issue Share Holding : 81.43%

Post Issue Share Holding : 54.29%

IPO - Issue Objectives
1